(Q44517505)

English

Novel role of 3-phosphoglycerate kinase, a glycolytic enzyme, in the activation of L-nucleoside analogs, a new class of anticancer and antiviral agents

scientific article published on 16 July 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Novel role of 3-phosphoglycerate kinase, a glycolytic enzyme, in the activation of L-nucleoside analogs, a new class of anticancer and antiviral agents (English)

1 reference

Europe PubMed Central

3 December 2017

author name string

Preethi Krishnan

1

1 reference

Europe PubMed Central

3 December 2017

Elizabeth A Gullen

2

1 reference

Europe PubMed Central

3 December 2017

Wing Lam

3

1 reference

Europe PubMed Central

3 December 2017

Ginger E Dutschman

4

1 reference

Europe PubMed Central

3 December 2017

Susan P Grill

5

1 reference

Europe PubMed Central

3 December 2017

Yung-Chi Cheng

6

1 reference

Europe PubMed Central

3 December 2017

language of work or name

0 references

publication date

16 July 2003

1 reference

Europe PubMed Central

3 December 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

3 December 2017

278

1 reference

Europe PubMed Central

3 December 2017

38

1 reference

Europe PubMed Central

3 December 2017

36726-36732

1 reference

Europe PubMed Central

3 December 2017

Potential use of antiviral L(-)nucleoside analogues for the prevention or treatment of viral associated cancers

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

New anti-HIV agents and targets

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Development and optimization of anti-HIV nucleoside analogs and prodrugs: A review of their cellular pharmacology, structure-activity relationships and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Understanding the unique mechanism of L-FMAU (clevudine) against hepatitis B virus: molecular dynamics studies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Hepatitis B virus: old, new and future approaches to antiviral treatment

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Perspectives for the treatment of hepatitis B virus infections

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Design and synthesis of 2',3'-dideoxy-2',3'-didehydro-beta-L-cytidine (beta-L-d4C) and 2',3'-dideoxy 2',3'-didehydro-beta-L-5-fluorocytidine (beta-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Pharmacokinetics and metabolism of racemic 2',3'-dideoxy-5-fluoro-3'-thiacytidine in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Comparative evaluation of L-Fd4C and related nucleoside analogs as promising antiviral agents

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Troxacitabine-based therapy of refractory leukemia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Mammalian deoxyribonucleoside kinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Phosphorylation of pyrimidine deoxynucleoside analog diphosphates: selective phosphorylation of L-nucleoside analog diphosphates by 3-phosphoglycerate kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Phosphorylation of pyrimidine L-deoxynucleoside analog diphosphates. Kinetics of phosphorylation and dephosphorylation of nucleoside analog diphosphates and triphosphates by 3-phosphoglycerate kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Gene silencing in mammals by small interfering RNAs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

RNA interference is mediated by 21- and 22-nucleotide RNAs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Nucleoside analogues: mechanisms of drug resistance and reversal strategies.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Nucleoside transporters: molecular biology and implications for therapeutic development

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Pre-steady state of reaction of nucleoside diphosphate kinase with anti-HIV nucleotides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Cellular phosphorylation of anti-HIV nucleosides. Role of nucleoside diphosphate kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307052200

21 January 2018

Identifiers

10.1074/JBC.M307052200

1 reference

Europe PubMed Central

3 December 2017

release_uv6eniv3gvfg5jeepsdisverwi

1 reference

https://api.fatcat.wiki/v0/release/uv6eniv3gvfg5jeepsdisverwi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44517505&oldid=2026604676"